Simona Cataldi
Overview
Explore the profile of Simona Cataldi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
113
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ambrosio M, Adriaens M, Derks K, Migliaccio T, Costa V, Liguoro D, et al.
Sci Rep
. 2024 Oct;
14(1):24674.
PMID: 39433816
An established hallmark of cancer cells is metabolic reprogramming, largely consisting in the exacerbated glucose uptake. Adipocytes in the tumor microenvironment contribute toward breast cancer (BC) progression and are highly...
2.
Aprile M, Cataldi S, Perfetto C, Federico A, Ciccodicola A, Costa V
Br J Cancer
. 2023 May;
129(2):249-265.
PMID: 37198319
Background: B-raf inhibitors (BRAFi) are effective for BRAF-mutated papillary (PTC) and anaplastic (ATC) thyroid carcinomas, although acquired resistance impairs tumour cells' sensitivity and/or limits drug efficacy. Targeting metabolic vulnerabilities is...
3.
Cataldi S, Aprile M, Perfetto C, Angot B, Cormont M, Ciccodicola A, et al.
Eur J Cell Biol
. 2023 May;
102(2):151320.
PMID: 37130450
Adipose tissue (AT) dysfunctions are associated with the onset of insulin resistance (IR) and type 2 diabetes mellitus (T2DM). Targeting glucose-dependent insulinotropic peptide receptor (GIPR) is a valid option to...
4.
Fasciolo G, Napolitano G, Aprile M, Cataldi S, Costa V, Muscari Tomajoli M, et al.
Antioxidants (Basel)
. 2023 Mar;
12(3).
PMID: 36978840
While a low level of ROS plays a role in cellular regulatory processes, a high level can lead to oxidative stress and cellular dysfunction. Insulin resistance (IR) is one of...
5.
Cataldi S, Tramontano M, Costa V, Aprile M, Ciccodicola A
Antioxidants (Basel)
. 2022 Oct;
11(10).
PMID: 36290744
The growing incidence of diabetes mellitus worldwide implies the increasing prevalence of several related macro- (e.g., hypertension and atherosclerosis) and micro-vascular (e.g., nephropathy and retinopathy) complications. Notably, diabetic retinopathy (DR)...
6.
Fasciolo G, Napolitano G, Aprile M, Cataldi S, Costa V, Ciccodicola A, et al.
Antioxidants (Basel)
. 2022 Jul;
11(7).
PMID: 35883786
Thyroid hormones are normally involved in glycaemic control, but their excess can lead to altered glucose metabolism and insulin resistance (IR). Since hyperthyroidism-linked increase in ROS results in tissue oxidative...
7.
Cataldi S, Aprile M, Melillo D, Mucel I, Giorgetti-Peraldi S, Cormont M, et al.
Cells
. 2022 Jan;
11(1).
PMID: 35011604
Low-grade chronic inflammation and reduced differentiation capacity are hallmarks of hypertrophic adipose tissue (AT) and key contributors of insulin resistance. We identified PPARGΔ5 as a dominant-negative splicing isoform overexpressed in...
8.
Cataldi S, Costa V, Ciccodicola A, Aprile M
Curr Diab Rep
. 2021 Apr;
21(6):18.
PMID: 33866450
Purpose Of Review: Full and partial synthetic agonists targeting the transcription factor PPARγ are contained in FDA-approved insulin-sensitizing drugs and used for the treatment of metabolic syndrome-related dysfunctions. Here, we...
9.
Aprile M, Cataldi S, Perfetto C, Ambrosio M, Italiani P, Tate R, et al.
Cells
. 2020 May;
9(5).
PMID: 32455814
Reduced neo-adipogenesis and dysfunctional lipid-overloaded adipocytes are hallmarks of hypertrophic obesity linked to insulin resistance. Identifying molecular features of hypertrophic adipocytes requires appropriate in vitro models. We describe the generation...
10.
Aprile M, Cataldi S, Ambrosio M, DEsposito V, Lim K, Dietrich A, et al.
Cell Rep
. 2018 Nov;
25(6):1577-1592.e6.
PMID: 30404011
Peroxisome-proliferator-activated receptor γ (PPARγ) regulates glucose and lipid homeostasis, insulin signaling, and adipocyte differentiation. Here, we report the skipping of exon 5 as a legitimate splicing event generating PPARγΔ5, a...